QuidelOrtho
QDEL
#4767
Rank
โ‚ฌ1.61 B
Marketcap
23,84ย โ‚ฌ
Share price
-0.22%
Change (1 day)
-34.05%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.

QuidelOrtho (QDEL) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚ฌ2.44 Billion

According to QuidelOrtho's latest financial reports the company's total debt is โ‚ฌ2.44 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

QuidelOrtho - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚ฌ2.57 B8.97%
2023-12-31โ‚ฌ2.36 B-10.97%
2022-12-31โ‚ฌ2.65 B2059.38%
2021-12-31โ‚ฌ0.12 B39.43%
2020-12-31โ‚ฌ88.21 M-12%
2019-12-31โ‚ฌ0.10 B6.61%
2018-12-31โ‚ฌ94.02 M-71.61%
2017-12-31โ‚ฌ0.33 B141.39%
2016-12-31โ‚ฌ0.13 B1.44%
2015-12-31โ‚ฌ0.13 B14.99%
2014-12-31โ‚ฌ0.11 B2818.49%
2013-12-31โ‚ฌ4.03 M-51.29%
2012-12-31โ‚ฌ8.27 M-78.41%
2011-12-31โ‚ฌ38.32 M-36.32%
2010-12-31โ‚ฌ60.18 M1175.37%
2009-12-31โ‚ฌ4.71 M-5.74%
2008-12-31โ‚ฌ5 M-5.85%
2007-12-31โ‚ฌ5.31 M-16.86%
2006-12-31โ‚ฌ6.39 M-48.5%
2005-12-31โ‚ฌ12.41 M74.07%
2004-12-31โ‚ฌ7.13 M-11.91%
2003-12-31โ‚ฌ8.09 M-20.51%
2002-12-31โ‚ฌ10.18 M-34.46%
2001-12-31โ‚ฌ15.54 M1.71%
2000-12-31โ‚ฌ15.28 M
1999-03-31โ‚ฌ2.77 M3%
1998-03-31โ‚ฌ2.69 M-5.88%
1997-03-31โ‚ฌ2.86 M-26.09%
1996-03-31โ‚ฌ3.87 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Meridian Bioscience
VIVO
โ‚ฌ26.58 M-98.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
โ‚ฌ16.61 B 580.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚ฌ30.64 B 1,154.66%๐Ÿ‡บ๐Ÿ‡ธ USA
OraSure Technologies
OSUR
โ‚ฌ11.56 M-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
โ‚ฌ14.47 B 492.73%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
โ‚ฌ3.87 B 58.58%๐Ÿ‡บ๐Ÿ‡ธ USA